A U.S. judge upheld two patents relating to Amgen Inc.’s blockbuster rheumatoid arthritis drug Enbrel, denying a challenge by Novartis AG, which is seeking to launch a copycat version.
Lawmakers seek scientific review of plan to tightly regulate all fentanyl copycats
Cancer Pain, Copycats, Crisis, Department of Health and Human Services (HHS), Drug Enforcement Agency (DEA), FDA, Fentanyl, Heroin, Legislation, Morphine, National Institute on Drug Abuse (NIDA), Opioids, Painkillers, Trump Administration, U.S. Justice Department, U.S. Senate Judiciary CommitteeLawmakers on the U.S. Senate Judiciary Committee urged the Trump administration to conduct a scientific review of a Justice Department-backed bill to classify all illicit chemical knockoffs of the potent painkiller fentanyl in the same legal category as heroin.